Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.88 USD | +5.04% | +7.50% | +4.24% |
05-09 | Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-26 | Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.24% | 462M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- NKTX Stock
- News Nkarta, Inc.
- Nkarta Says Leukemia Drug Showed 'Encouraging' Results in Phase 1 Study